HealthDay on MSN
FDA to review whether to allow more access to certain peptides
Key Takeaways Seven peptides that are now restricted will undergo U.S. Food and Drug Administration reviewHealth Secretary ...
The FDA’s former top drug regulator Richard Pazdur, M.D., has lamented the loss of expert voices at the agency. | Asked by ...
The FDA commissioner blocked new flavors like mango and blueberry despite scientific staff signoff.
The FDA may allow broader access to testosterone therapy for men with low libido without known medical cause. Manufacturers ...
“Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ALS, will likely get rolled out within the next few years, Food and Drug ...
Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, ...
The U. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, ...
The Trump administration recently celebrated one year of embracing the movement to Make America Healthy Again. Unfortunately, many of these successes are overshadowed by slapdash decision-making at ...
The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good ...
Dr. Houman Hemmati, an ophthalmologist critical of the government’s Covid vaccine response, is the front-runner for the role ...
WASHINGTON (AP) — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after ...
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results